Option chain shows key data for GT Biopharma's stock options at various strike prices and expiration dates. Traders use this information to analyze potential trades and assess market sentiment for GT Biopharma.

GT Biopharma (NASDAQ:GTBP) Stock, Option Chain

GT Biopharma

GT Biopharma Inc is a clinical-stage biopharmaceutical company focused on the development and commercialization of novel immuno-oncology products in the United States. It is engaged in discovering, developing, and commercializing novel therapeutics from its proprietary product platform in a varied range of disease areas. The company mainly develops drugs focused on the treatment of cancer. Its TriKE (Tri-specific Killer Engager) platforms offer immuno-oncology products that can treat a range of hematologic malignancies, sarcoma, and solid tumors.

accounting-761599_1280

News

Offerings

Movers

GTBP

GT Biopharma entered into a definitive securities purchase agreement for the purchase and sale of 740,000 shares of its common stock at a purchase price of $4.35 per share. The shares will be offered in a registered direct offering priced at-the-market under Nasdaq rules. 

What&#39;s Going On With GT Biopharma Stock Tuesday?

pharmaceutical

GT Biopharma shares are moving on heavy trading volume despite a lack of company-specific news. The stock is one of the top trending tickers on Stocktwits which may point to a rally led by retail traders. According to data from Benzinga Pro, more than 60.4 million shares have been traded in the session, far exceeding the stock&#39;s 100-day average of less than 11,000 shares.

What&#39;s Going On With GT Biopharma Stock?

movers image

Intraday Update

Markets

AKAN

AKTS

BCAN

BNED

BRSH

CETX

CMCM

CNEY

CRKN

CRVO

CTNT

DMTK

DOCS

FFIE

Hims & Hers Health, Inc. Class A Common Stock

HIMS

HLTH

IBTX

IGMS

JAGX

JFBR

MIRA

Eaton Vance Massachusetts Municipal Income Trust

NKGN

NMHI

OKLO

PTCT

REKR

RERE

SCLX

SCPX

SINT

SISI

SKIN

STRO

TANH

TELL

VIRI

Why Virios Therapeutics Shares Are Trading Lower By Around 48%? Here Are Other Stocks Moving In Monday&#39;s Mid-Day Session

GT Biopharma Inc

Press Releases

GT Biopharma Announces FDA Clearance of Investigational New Drug (IND) Application for GTB-3650, an NK Cell Engager for Treatment of CD33+ Leukemia

GT Biopharma Reports Second Quarter 2024 Financial Results and Provides Corporate Update

GT Biopharma to Host Virtual KOL Event Showcasing its NK Cell Engager Pipeline and Broad Indication Potential on October 10, 2024

GT Biopharma to Participate in the 3rd Annual ROTH Healthcare Opportunities Conference

GT Biopharma Reports Third Quarter 2024 Financial Results

GT Biopharma Announces First Patient Dosed in Phase 1 Trial of GTB-3650, Second-Generation TriKE for the Treatment of Hematologic Malignancies

GT Biopharma Announces Request for Withdrawal of Form S-1 Registration Statement

GT Biopharma Announces Exercise of Warrants

"Signal Advance, Inc. (OTC: SIGL) Achieves Technology Milestone with Revolutionary Next-Gen Signal Protection – More Stocks Inside"

GT Biopharma to Participate in the 10th Anniversary of the Innate Killer Summit

BNZI

CSDX

MBRX

SIGL

SKYX

Acurx Pharmaceuticals, Inc. - Common Stock

Acurx Pharmaceuticals

Aditxt

AEON Biopharma, Inc. Class A Common Stock

AEON Biopharma

Alzamend Neuro

Aptorum Group Limited - Class A Ordinary Shares

Aptorum Gr

Azitra

Brainstorm Cell Therapeutics Inc. - Common Stock

Brainstorm Cell

Creative Medical Technology Holdings, Inc. - Common Stock

Creative Medical Tech

Cyclerion Therapeutics, Inc. - Common Stock

Cyclerion Therapeutics

Dermata Therapeutics, Inc. - Common Stock

Dermata Therapeutics

Indaptus Therapeutics, Inc. - Common Stock

Indaptus Therapeutics

Klotho Neurosciences, Inc. - Common Stock

Klotho Neurosciences

Lipella Pharmaceuticals Inc. - Common Stock

Lipella Pharmaceuticals

Mainz Biomed

NuCana

Ocean Biomedical

Oragenics

Phio Pharmaceuticals Corp. - Common Stock

Phio Pharma

Plus Therapeutics

Quoin Pharmaceuticals, Ltd. - American Depositary Shares

Quoin Pharmaceuticals

Sunshine Biopharma

SILO Pharma

Soligenix

Alaunos Therapeutics, Inc. - Common Stock

Alaunos Therapeutics

XTL Biopharmaceuticals Ltd. - American Depositary Shares

XTL Biopharmaceuticals

Roth MKM

HC Wainwright & Co.

EF Hutton

Comments

GT Biopharma

GT Biopharma (GTBP) Options

No option chain data available. Please try again later

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga